Five years ago, Sharon Schafer Bennett suffered from migraines so severe that the headaches disrupted her life, kept her from seeking a job and interfered with participation in her children?s daily activities.
An estimated 10 million Americans have osteoporosis, and an additional 34 million are estimated to have low bone mass, placing them at increased risk for developing this condition.
Researchers at Mount Sinai School of Medicine have just developed an advanced imaging technique to capture the movement of the microdomains of leukocytes or white blood cells.
Mayo Clinic researchers have safely transplanted cardiac preprogrammed embryonic stem cells into diseased hearts of mice successfully regenerating infarcted heart muscle without precipitating the growth of a cancerous tumor — which, so far, has impeded successful translation into practice of embryonic stem cell research.
Using a cognitive behavioral therapy called “prolonged exposure” appears more effective than “present-centered” therapy, a supportive intervention to treat female military veterans and active duty women with posttraumatic stress disorder, according to a study in the Feb. 28 issue of JAMA.
A new report from the World Health Organization (WHO) shows that neurological disorders, ranging from epilepsy to Alzheimer disease, from stroke to headache, affect up to one billion people worldwide.
MIT researchers have developed a technique to encourage the survival and growth of adult stem cells, a step that could help realize the therapeutic potential of such cells.
Exercise testing can be a powerful tool for diagnosing chronic heart and lung conditions and measuring responses to treatment, according to new research published in the European Respiratory Journal.
Contrary to popular wisdom, heart disease is not primarily a male disease, and is in fact statistically far more deadly when it occurs in women. Most women are not aware that heart disease is the number one killer of women, far greater than any other disease.
Adcock Ingram, South Africa?s largest pharmaceutical company, is set to start manufacturing antiretrovirals (ARVs) with immediate effect, following approval by the Medicines Control Council (MCC).